Philip Morris' moves to reinvent the cigarette haven't swayed critics of Big Tobacco

Philip Morris brand cigarettes are displayed for sale at a gas station in Tiskilwa, Ill., on July 12, 2017. Photo: Daniel Acker

When Moira Gilchrist was first approached by Philip Morris International Inc., she wondered what a tobacco company wanted from a scientist who had previously worked on clinical trials for anti-cancer drugs.

The world's largest cigarette maker was looking at ways of delivering nicotine in a product that reduced the harmful chemicals in smoking, and needed her expertise in navigating the highly regulated pharmaceutical industry. Gilchrist, a cigarette smoker at the time, made the leap in 2006 - to the shock of friends and colleagues - becoming one of the first people from the pharma sector to join Big Tobacco, viewed by many as the enemy of health...

Læs også